Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324


Absence of MHC class II on cDC1 dendritic cells triggers fatal autoimmunity to a cross-presented self-antigen.

Wohn C, Le Guen V, Voluzan O, Fiore F, Henri S, Malissen B.

Sci Immunol. 2020 Mar 13;5(45). pii: eaba1896. doi: 10.1126/sciimmunol.aba1896.


On-farm use of a water hardness test kit to assess total blood calcium level in dairy cattle.

Fiore F, Cocco R, Musina D, Spissu N.

J Dairy Res. 2020 Feb;87(1):56-59. doi: 10.1017/S0022029920000023. Epub 2020 Feb 3.


Deleterious impact of a generic temozolomide formulation compared with brand-name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma.

Fontanilles M, Fontanilles A, Massy N, Rouvet J, Pereira T, Alexandru C, Hanzen C, Basuyau F, Langlois O, Clatot F, Tennevet I, Di Fiore F, Joannidès R, Lamoureux F.

Fundam Clin Pharmacol. 2020 Jan 29. doi: 10.1111/fcp.12539. [Epub ahead of print]


Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.

Clatot F, Fontanilles M, Lefebvre L, Lequesne J, Veyret C, Alexandru C, Leheurteur M, Guillemet C, Gouérant S, Petrau C, Théry JC, Rigal O, Moldovan C, Tennevet I, Rastelli O, Poullain A, Savary L, Bubenheim M, Georgescu D, Gouérant J, Gilles-Baray M, Di Fiore F.

Eur J Cancer. 2020 Feb;126:116-124. doi: 10.1016/j.ejca.2019.11.022. Epub 2020 Jan 10.


Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study.

Randrian V, Adenis A, Desrame J, Barbier E, Di Fiore F, Lièvre A, Dahan L, Laurent-Puig P, Mineur L, Breysacher G, Roquin G, Louafi S, Lopez A, Louvet C, Borg C, Metges JP, Faroux R, Gaba L, Manfredi S, Tougeron D.

Dig Liver Dis. 2020 Mar;52(3):347-350. doi: 10.1016/j.dld.2019.11.014. Epub 2019 Dec 30.


Surgical recurrence of solitary fibrous tumor of the pleura treated with microwave (MW) thermoablation: A case report.

Fiore F, Stoia V, Somma F.

Thorac Cancer. 2020 Feb;11(2):443-446. doi: 10.1111/1759-7714.13263. Epub 2019 Dec 26.


Evaluation of Oxidative Stress in Dairy Cows with Left Displacement of Abomasum.

Fiore F, Spissu N, Sechi S, Cocco R.

Animals (Basel). 2019 Nov 13;9(11). pii: E966. doi: 10.3390/ani9110966.


Patients' perception and attitude to totally implantable venous access for urologic or digestive cancer: A cross-sectional study.

Vermeulin T, Lahbib H, Lottin M, Brifault C, Diot J, Lucas M, Huet E, Di Fiore F, Michel P, Czernichow P, Merle V.

Bull Cancer. 2019 Nov;106(11):959-968. doi: 10.1016/j.bulcan.2019.09.004. Epub 2019 Oct 14.


Quantitative interactomics in primary T cells unveils TCR signal diversification extent and dynamics.

Voisinne G, Kersse K, Chaoui K, Lu L, Chaix J, Zhang L, Goncalves Menoita M, Girard L, Ounoughene Y, Wang H, Burlet-Schiltz O, Luche H, Fiore F, Malissen M, Gonzalez de Peredo A, Liang Y, Roncagalli R, Malissen B.

Nat Immunol. 2019 Nov;20(11):1530-1541. doi: 10.1038/s41590-019-0489-8. Epub 2019 Oct 7.


Doege-Potter syndrome by malignant solitary fibrous tumor of the liver: A case report and review of literature.

Delvecchio A, Duda L, Conticchio M, Fiore F, Lafranceschina S, Riccelli U, Cristofano A, Pascazio B, Colagrande A, Resta L, Memeo R.

World J Gastrointest Surg. 2019 Aug 27;11(8):348-357. doi: 10.4240/wjgs.v11.i8.348.


Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy.

Lambertini M, Olympios N, Lequesne J, Calbrix C, Fontanilles M, Loeb A, Leheurteur M, Demeestere I, Di Fiore F, Perdrix A, Clatot F.

Front Oncol. 2019 Jul 12;9:575. doi: 10.3389/fonc.2019.00575. eCollection 2019.


TERTp Mutation Detection in Plasma by Droplet-Digital Polymerase Chain Reaction in Spinal Myxopapillary Ependymoma with Lung Metastases.

Deniel A, Marguet F, Beaussire L, Tobenas-Dujardin AC, Peillon C, Gambirasio MA, Veresezan O, Magne N, Di Fiore F, Laquerrière A, Sarafan-Vasseur N, Fontanilles M.

World Neurosurg. 2019 Oct;130:405-409. doi: 10.1016/j.wneu.2019.07.111. Epub 2019 Jul 19.


Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy.

Celis-Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Grégoire C, Ounoughene Y, Fiore F, Aebersold R, Roncagalli R, Gstaiger M, Malissen B.

Cell Rep. 2019 Jun 11;27(11):3315-3330.e7. doi: 10.1016/j.celrep.2019.05.041.


Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.

Somma F, Stoia V, Serra N, D'Angelo R, Gatta G, Fiore F.

PLoS One. 2019 May 29;14(5):e0216935. doi: 10.1371/journal.pone.0216935. eCollection 2019.


Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.

Rambeau A, Bastit V, Thureau S, Thariat J, Moldovan C, Roge M, Babin E, Gery B, Di Fiore F, Florescu C, Clatot F.

Oral Oncol. 2019 Jun;93:46-51. doi: 10.1016/j.oraloncology.2019.04.005. Epub 2019 Apr 15.


"Laparoscopic Para-Aortic Lymph Node Sampling" First Approach for Pancreatic Adenocarcinoma as an Oncological Practice.

Schwarz L, Tortajada P, Pittau G, Di Fiore F, Sefrioui D, Bridoux V, Laurenzi A, Tuech JJ, Sa Cunha A.

J Laparoendosc Adv Surg Tech A. 2019 Jul;29(7):900-904. doi: 10.1089/lap.2018.0775. Epub 2019 Mar 12.


Fibonacci's Golden Ratio-An Innovative Approach to the Design and Management of Extra-Corporeal Circulation.

Condello I, Nasso G, Fiore F, Azzolina S, Bonifazi R, Di Bari N, Bartolomucci F, Massaro F, Speziale G.

Surg Technol Int. 2019 May 15;34:340-350.


Dopamine Optimizes Venous Return During Cardiopulmonary Bypass and Reduces the Need for Postoperative Blood Transfusion.

Moscarelli M, Condello I, Fattouch K, Punjabi P, Ajello V, Solimando C, Fiore F, Angelini G, Speziale G.

ASAIO J. 2019 Nov/Dec;65(8):882-887. doi: 10.1097/MAT.0000000000000930.


FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group.

N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.


Evaluation of the current status of the eye lens radiation exposure in an Interventional Radiology department.

Pugliese M, Amatiello A, Correra M, Stoia V, Cerciello V, Roca V, Loffredo F, Fiore F, La Verde G.

Med Lav. 2018 Dec 20;109(6):471-477. doi: 10.23749/mdl.v110i6.7286.


Benefit of cetuximab addition to a platinum-fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers.

Bastit V, Bon-Mardion N, Picquenot JM, Rainville V, Moldovan C, François A, Loeb A, Thureau S, Manu D, Jardin F, Marie JP, Di Fiore F, Clatot F.

Eur Arch Otorhinolaryngol. 2019 Feb;276(2):541-550. doi: 10.1007/s00405-018-5235-6. Epub 2018 Dec 6.


CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts.

Laurent L, Sefrioui D, Bignon AL, Parzy A, Sidali S, Hassine M, Gangloff A, Galais MP, Bouhier-Leporrier K, Michel P, Di Fiore F.

HPB (Oxford). 2019 May;21(5):582-588. doi: 10.1016/j.hpb.2018.09.006. Epub 2018 Nov 20.


Role of rumination in the relationship between metacognition and shyness.

Palmieri S, Mansueto G, Scaini S, Fiore F, Sassaroli S, Ruggiero GM, Borlimi R, Carducci BJ.

World J Psychiatry. 2018 Oct 14;8(4):108-113. doi: 10.5498/wjp.v8.i4.108. eCollection 2018 Oct 14.


FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial.

Bachet JB, Lucidarme O, Levache CB, Barbier E, Raoul JL, Lecomte T, Desauw C, Brocard F, Pernot S, Breysacher G, Lagasse JP, Di Fiore F, Etienne PL, Dupuis OJM, Aleba A, Lepage C, Taieb J; for FFCD 1102 investigators.

Eur J Cancer. 2018 Nov;104:108-116. doi: 10.1016/j.ejca.2018.09.006. Epub 2018 Oct 18.


Association between left-displaced abomasum corrected with 2-step laparoscopic abomasopexy and milk production in a commercial dairy farm in Italy.

Fiore F, Musina D, Cocco R, Di Cerbo A, Spissu N.

Ir Vet J. 2018 Oct 9;71:20. doi: 10.1186/s13620-018-0132-2. eCollection 2018.


Totally implanted venous access-associated adverse events in oncology: Results from a prospective 1-year surveillance programme.

Vermeulin T, Lucas M, Marini H, Di Fiore F, Loeb A, Lottin M, Daubert H, Gray C, Guisier F, Sefrioui D, Michel P, de Mil R, Czernichow P, Merle V.

Bull Cancer. 2018 Nov;105(11):1003-1011. doi: 10.1016/j.bulcan.2018.09.005. Epub 2018 Oct 12.


Correction to: EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.

Zjablovskaja P, Kardosova M, Danek P, Angelisova P, Benoukraf T, Wurm AA, Kalina T, Sian S, Balastik M, Delwel R, Brdicka T, Tenen DG, Behre G, Fiore F, Malissen B, Horejsi V, Alberich-Jorda M.

Cell Death Differ. 2019 Jan;26(1):198. doi: 10.1038/s41418-018-0146-z.


Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients.

Fontanilles M, Marguet F, Alexandru C, Langlois O, Veresezan O, Gilard V, David M, Laquerriere A, Hanzen C, Tennevet I, Di Fiore F, Clatot F.

Support Care Cancer. 2019 Feb;27(2):477-484. doi: 10.1007/s00520-018-4336-5. Epub 2018 Jul 5.


Observations of the missing baryons in the warm-hot intergalactic medium.

Nicastro F, Kaastra J, Krongold Y, Borgani S, Branchini E, Cen R, Dadina M, Danforth CW, Elvis M, Fiore F, Gupta A, Mathur S, Mayya D, Paerels F, Piro L, Rosa-Gonzalez D, Schaye J, Shull JM, Torres-Zafra J, Wijers N, Zappacosta L.

Nature. 2018 Jun;558(7710):406-409. doi: 10.1038/s41586-018-0204-1. Epub 2018 Jun 20.


Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients.

Allouchery V, Beaussire L, Perdrix A, Sefrioui D, Augusto L, Guillemet C, Sarafan-Vasseur N, Di Fiore F, Clatot F.

Breast Cancer Res. 2018 May 16;20(1):40. doi: 10.1186/s13058-018-0968-0.


Adverse food reactions in dogs due to antibiotic residues in pet food: a preliminary study.

Di Cerbo A, Canello S, Guidetti G, Fiore F, Corsi L, Rubattu N, Testa C, Cocco R.

Vet Ital. 2018 Jun 30;54(2):137-146. doi: 10.12834/VetIt.1357.7466.2.


Clinical Relevance of Gene Copy Number Variation in Metastatic Clear Cell Renal Cell Carcinoma.

Nouhaud FX, Blanchard F, Sesboue R, Flaman JM, Sabourin JC, Pfister C, Di Fiore F.

Clin Genitourin Cancer. 2018 Aug;16(4):e795-e805. doi: 10.1016/j.clgc.2018.02.013. Epub 2018 Feb 23.


Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies.

Sangro B, Maini CL, Ettorre GM, Cianni R, Golfieri R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Van Buskirk M, Bilbao JI, Salvatori R, Giampalma E, Geatti O, Wilhelm K, Hoffmann RT, Izzo F, Iñarrairaegui M, Urigo C, Cappelli A, Vit A, Ahmadzadehfar H, Jakobs TF, Sciuto R, Pizzi G, Lastoria S; European Network on Radioembolization with Yttrium-90 resin microspheres (ENRY).

Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1721-1730. doi: 10.1007/s00259-018-3968-5. Epub 2018 Mar 7.


Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal.

Baranska A, Shawket A, Jouve M, Baratin M, Malosse C, Voluzan O, Vu Manh TP, Fiore F, Bajénoff M, Benaroch P, Dalod M, Malissen M, Henri S, Malissen B.

J Exp Med. 2018 Apr 2;215(4):1115-1133. doi: 10.1084/jem.20171608. Epub 2018 Mar 6.


Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK).

Michel P, Boige V, Andre T, Aparicio T, Bachet JB, Dahan L, Guimbaud R, Lepage C, Manfredi S, Tougeron D, Taieb J, Selves J, Le Malicot K, Di Fiore F, Maillard E.

Dig Liver Dis. 2018 Mar;50(3):305-307. doi: 10.1016/j.dld.2017.12.023. Epub 2017 Dec 30.


Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.

Lange M, Laviec H, Castel H, Heutte N, Leconte A, Léger I, Giffard B, Capel A, Dubois M, Clarisse B, Coquan E, Di Fiore F, Gouérant S, Bartélémy P, Pierard L, Fizazi K, Joly F.

BMC Cancer. 2018 Jan 30;18(1):110. doi: 10.1186/s12885-017-3764-9.


[Aspirin and colorectal cancer].

Grancher A, Michel P, Di Fiore F, Sefrioui D.

Bull Cancer. 2018 Feb;105(2):171-180. doi: 10.1016/j.bulcan.2017.09.013. Epub 2017 Nov 15. Review. French.


[Clinical relevance of ESR1 circulating mutations detection in hormone receptor positive metastatic breast cancer].

Clatot F, Perdrix A, Sefrioui D, Sarafan-Vasseur N, Di Fiore F.

Bull Cancer. 2018 Jan;105(1):46-54. doi: 10.1016/j.bulcan.2017.09.002. Epub 2017 Oct 9. Review. French.


Mid-Term Performance of Bipolar Radiofrequency Ablation for Isolated Atrial Fibrillation Through a Right Minithoracotomy.

Nasso G, Moscarelli M, Fattouch K, Zebele C, Iacopino S, Fiore F, Speziale G.

Semin Thorac Cardiovasc Surg. 2017 Summer;29(2):160-172. doi: 10.1053/j.semtcvs.2017.01.005. Epub 2017 Jan 14.


Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.

Lange M, Laviec H, Castel H, Heutte N, Leconte A, Léger I, Giffard B, Capel A, Dubois M, Clarisse B, Coquan E, Di Fiore F, Gouérant S, Bartélémy P, Pierard L, Fizazi K, Joly F.

BMC Cancer. 2017 Aug 16;17(1):549. doi: 10.1186/s12885-017-3534-8. Erratum in: BMC Cancer. 2018 Jan 30;18(1):110.


Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.

Sefrioui D, Blanchard F, Toure E, Basile P, Beaussire L, Dolfus C, Perdrix A, Paresy M, Antonietti M, Iwanicki-Caron I, Alhameedi R, Lecleire S, Gangloff A, Schwarz L, Clatot F, Tuech JJ, Frébourg T, Jardin F, Sabourin JC, Sarafan-Vasseur N, Michel P, Di Fiore F.

Br J Cancer. 2017 Sep 26;117(7):1017-1025. doi: 10.1038/bjc.2017.250. Epub 2017 Aug 3.


Heparinase enables reliable quantification of circulating tumor DNA from heparinized plasma samples by droplet digital PCR.

Sefrioui D, Beaussire L, Clatot F, Delacour J, Perdrix A, Frebourg T, Michel P, Di Fiore F, Sarafan-Vasseur N.

Clin Chim Acta. 2017 Sep;472:75-79. doi: 10.1016/j.cca.2017.07.015. Epub 2017 Jul 17.


Oxidative stress and food supplementation with antioxidants in therapy dogs.

Sechi S, Fiore F, Chiavolelli F, Dimauro C, Nudda A, Cocco R.

Can J Vet Res. 2017 Jul;81(3):206-216.


Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer.

Perdrix A, Saint-Ghislain M, Degremont M, David M, Khaznadar Z, Loeb A, Leheurteur M, Di Fiore F, Clatot F.

Reprod Biomed Online. 2017 Oct;35(4):468-474. doi: 10.1016/j.rbmo.2017.06.005. Epub 2017 Jun 15.


Direct circulating tumor DNA detection from unpurified plasma using a digital PCR platform.

Sefrioui D, Beaussire L, Perdrix A, Clatot F, Michel P, Frebourg T, Di Fiore F, Sarafan-Vasseur N.

Clin Biochem. 2017 Nov;50(16-17):963-966. doi: 10.1016/j.clinbiochem.2017.06.005. Epub 2017 Jun 20.


Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study).

Garlan F, Laurent-Puig P, Sefrioui D, Siauve N, Didelot A, Sarafan-Vasseur N, Michel P, Perkins G, Mulot C, Blons H, Taieb J, Di Fiore F, Taly V, Zaanan A.

Clin Cancer Res. 2017 Sep 15;23(18):5416-5425. doi: 10.1158/1078-0432.CCR-16-3155. Epub 2017 Jun 2.


Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours.

Lepage C, Dahan L, Bouarioua N, Toumpanakis C, Legoux JL, Le Malicot K, Guimbaud R, Smith D, Tougeron D, Lievre A, Cadiot G, Di Fiore F, Bouhier-Leporrier K, Hentic O, Faroux R, Pavel M, Borbath I, Valle JW, Rinke A, Scoazec JY, Ducreux M, Walter T.

Dig Liver Dis. 2017 May;49(5):568-571. doi: 10.1016/j.dld.2017.02.004. Epub 2017 Mar 11.


Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.

Desbordes P, Ruan S, Modzelewski R, Pineau P, Vauclin S, Gouel P, Michel P, Di Fiore F, Vera P, Gardin I.

PLoS One. 2017 Mar 10;12(3):e0173208. doi: 10.1371/journal.pone.0173208. eCollection 2017.


EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.

Zjablovskaja P, Kardosova M, Danek P, Angelisova P, Benoukraf T, Wurm AA, Kalina T, Sian S, Balastik M, Delwel R, Brdicka T, Tenen DG, Behre G, Fiore F, Malissen B, Horejsi V, Alberich-Jorda M.

Cell Death Differ. 2017 Apr;24(4):705-716. doi: 10.1038/cdd.2017.6. Epub 2017 Feb 10. Erratum in: Cell Death Differ. 2019 Jan;26(1):198.


ESR1 mutations in breast cancer.

Clatot F, Augusto L, Di Fiore F.

Aging (Albany NY). 2017 Jan 25;9(1):3-4. doi: 10.18632/aging.101165. No abstract available.

Supplemental Content

Support Center